Literature DB >> 21880669

Novel O-linked glycans containing 6'-sulfo-Gal/GalNAc of MUC1 secreted from human breast cancer YMB-S cells: possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibody.

Akira Seko1, Takashi Ohkura, Hiroko Ideo, Katsuko Yamashita.   

Abstract

Human serum Krebs von den Lugen-6 (KL-6) antigen is a MUC1 glycoprotein (KL-6/MUC1) recognized by anti-KL-6 monoclonal antibody (KL-6/mAb) and has been utilized as a diagnostic marker for interstitial pneumonia. KL-6/mAb is thought to recognize the specific glycopeptides sequence of MUC1, but the precise glycan structure of the epitope is unclear. In this study, we determined the carbohydrate structures of KL-6/MUC1 to search the carbohydrate epitopes for KL-6/mAb. KL-6/MUC1 was purified from the culture medium of human breast cancer YMB-S cells by KL-6/mAb-affinity chromatography; the O-linked glycan structures were determined in combination with paper electrophoresis, several lectin column chromatographies, sialidase digestion and methanolysis. KL-6/MUC1 contained core 1 and extended core 1 glycans modified with one or two sialic acid/sulfate residues. Based on these structures, several synthetic glycans binding to anti-KL-6/mAb were compared with one another by surface plasmon resonance. Sequentially, related radiolabeled oligosaccharides were enzymatically synthesized and analyzed for binding to a KL-6/mAb-conjugated affinity column. 3'-sialylated, 6'-sulfated LNnT [Neu5Acα2-3(SO(3)(-)-6)Galβ1-4GlcNAcβ1-3Galβ1-4Glc], 3'-sialylated, 6-sulfated core 1 [Neu5Acα2-3Galβ1-3(SO(3)(-)-6)GalNAc] and disulfated core 1 SO(3)(-)-3Galβ1-3(SO(3)(-)-6)GalNAc exhibited substantial affinity for KL-6/mAb, and 3'-sulfated core 1 derivatives [SO(3)(-)-3Galβ1-3(±Neu5Acα2-6)GalNAc] and 3'-sialylated core 1 weakly interacted with KL-6/mAb. These results indicated that the possible carbohydrate epitopes of KL-6/mAb involve not only 3'-sialylated core 1 but also novel core 1 and extended core 1 with sulfate and sialic acid residues. Epitope expressing changes with suppression or over-expression of the Gal6ST (Gal 6-O-sulfotransferase) gene, suggesting that Gal6ST is involved in the biosynthesis of the unique epitopes of KL-6/mAb.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880669     DOI: 10.1093/glycob/cwr118

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  15 in total

1.  Shotgun glycomics of pig lung identifies natural endogenous receptors for influenza viruses.

Authors:  Lauren Byrd-Leotis; Renpeng Liu; Konrad C Bradley; Yi Lasanajak; Sandra F Cummings; Xuezheng Song; Jamie Heimburg-Molinaro; Summer E Galloway; Marie R Culhane; David F Smith; David A Steinhauer; Richard D Cummings
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

Review 2.  Modifications of glycans: biological significance and therapeutic opportunities.

Authors:  Saddam M Muthana; Christopher T Campbell; Jeffrey C Gildersleeve
Journal:  ACS Chem Biol       Date:  2012-01-11       Impact factor: 5.100

3.  Directed evolution of lectins with sugar-binding specificity for 6-sulfo-galactose.

Authors:  Dan Hu; Hiroaki Tateno; Atsushi Kuno; Rikio Yabe; Jun Hirabayashi
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

4.  Selected reaction monitoring to differentiate and relatively quantitate isomers of sulfated and unsulfated core 1 O-glycans from salivary MUC7 protein in rheumatoid arthritis.

Authors:  Sarah A Flowers; Liaqat Ali; Catherine S Lane; Magnus Olin; Niclas G Karlsson
Journal:  Mol Cell Proteomics       Date:  2013-03-01       Impact factor: 5.911

5.  Podocalyxin is a glycoprotein ligand of the human pluripotent stem cell-specific probe rBC2LCN.

Authors:  Hiroaki Tateno; Asako Matsushima; Keiko Hiemori; Yasuko Onuma; Yuzuru Ito; Kayo Hasehira; Ken Nishimura; Manami Ohtaka; Satoko Takayasu; Mahito Nakanishi; Yuzuru Ikehara; Mio Nakanishi; Kiyoshi Ohnuma; Techuan Chan; Masashi Toyoda; Hidenori Akutsu; Akihiro Umezawa; Makoto Asashima; Jun Hirabayashi
Journal:  Stem Cells Transl Med       Date:  2013-03-22       Impact factor: 6.940

Review 6.  Clinicopathological utility of sialoglycoconjugates in diagnosing and treating colorectal cancer.

Authors:  Yoshinori Inagaki; Jianjun Gao; Peipei Song; Norihiro Kokudo; Munehiro Nakata; Wei Tang
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

7.  The Diagnostic Value of the Interstitial Biomarkers KL-6 and SP-D for the Degree of Fibrosis in Combined Pulmonary Fibrosis and Emphysema.

Authors:  Shigeki Chiba; Hiromitsu Ohta; Kyoko Abe; Shu Hisata; Shinya Ohkouchi; Yasushi Hoshikawa; Takashi Kondo; Masahito Ebina
Journal:  Pulm Med       Date:  2012-02-28

8.  Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression.

Authors:  Sho Sato; Tomomi Kato; Kenji Abe; Tatsuya Hanaoka; Yuri Yano; Akira Kurosaki; Masanori Yasuda; Tetsuo Sekino; Keiichi Fujiwara; Kosei Hasegawa
Journal:  Oncol Lett       Date:  2017-05-25       Impact factor: 2.967

9.  Distinct Cytoplasmic Expression of KL-6 Mucin in Chromophobe Renal Cell Carcinoma: A Comparative Immunohistochemical Study with Other Renal Epithelial Cell Tumors.

Authors:  Mana Fukushima; Kayoko Higuchi; Hisashi Shimojo; Takeshi Uehara; Hiroyoshi Ota
Journal:  Acta Histochem Cytochem       Date:  2012-09-11       Impact factor: 1.938

10.  KL-6, a Human MUC1 Mucin, as a prognostic marker for diffuse alveolar hemorrhage syndrome.

Authors:  Yoshiko Kida; Shinichiro Ohshimo; Kohei Ota; Tomoko Tamura; Tadatsugu Otani; Kazunobu Une; Takuma Sadamori; Yasumasa Iwasaki; Francesco Bonella; Noboru Hattori; Nobuyuki Hirohashi; Josune Guzman; Ulrich Costabel; Nobuoki Kohno; Koichi Tanigawa
Journal:  Orphanet J Rare Dis       Date:  2012-12-17       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.